Hpmcs | List of Frontiers open access articles

Original Research

Published on 30 Aug 2021

Requirement of Histone Deacetylase 6 for Interleukin-6 Induced Epithelial-Mesenchymal Transition, Proliferation, and Migration of Peritoneal Mesothelial Cells

in Experimental Pharmacology and Drug Discovery

Yingfeng Shi
Min Tao
Jun Ni
Lunxian Tang
Feng Liu
Hui Chen
Xiaoyan Ma
Yan Hu
Xun Zhou
Andong Qiu

Frontiers in Pharmacology

doi 10.3389/fphar.2021.722638

4,832 views
27 citations

Original Research

Published on 20 Dec 2022

Long-term peritoneal dialysate exposure modulates expression of membrane complement regulators in human peritoneal mesothelial cells

in Nephrology

Kazuma Kobayashi
Toshikazu Ozeki
Hangsoo Kim
Masaki Imai
Hiroshi Kojima
Daiki Iguchi
Sosuke Fukui
Masafumi Suzuki
Yasuhiro Suzuki
Shoichi Maruyama

Frontiers in Medicine

doi 10.3389/fmed.2022.972592

2,900 views

Original Research

Published on 03 Sep 2021

Thalidomide Suppresses Angiogenesis Through the Signal Transducer and Activator of Transcription 3/SP4 Signaling Pathway in the Peritoneal Membrane

in Renal Physiology and Pathophysiology

Nan Zhu
Ling Wang
Huimin Guo
Jieshuang Jia
Lijie Gu
Xuan Wang
Man Yang
Haochen Guan
Weijie Yuan

Frontiers in Physiology

doi 10.3389/fphys.2021.712147

6,621 views
10 citations

Original Research

Published on 23 Sep 2022

Endoglin aggravates peritoneal fibrosis by regulating the activation of TGF-β/ALK/Smads signaling

in Renal Pharmacology

Qian Huang
Rui Xiao
Jing Lu
Yao Zhang
Liang Xu
Jie Gao
Jing Sun
Haiping Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.973182

4,036 views
11 citations

Original Research

Published on 21 Jun 2022

Elabela Attenuates the TGF-β1-Induced Epithelial-Mesenchymal Transition of Peritoneal Mesothelial Cells in Patients Receiving Peritoneal Dialysis

in Experimental Pharmacology and Drug Discovery

Shunyun Xie
Feng Xu
Yue Lu
Yixian Zhang
Xinyang Li
Mengyuan Yu
Wenpeng Cui

Frontiers in Pharmacology

doi 10.3389/fphar.2022.890881

4,777 views
14 citations

Original Research

Published on 30 Aug 2021

LncRNA GAS5 Competitively Combined With miR-21 Regulates PTEN and Influences EMT of Peritoneal Mesothelial Cells via Wnt/β-Catenin Signaling Pathway

in Renal Physiology and Pathophysiology

Yi Fan
Xingxu Zhao
Jianfei Ma
Lina Yang

Frontiers in Physiology

doi 10.3389/fphys.2021.654951

4,176 views
24 citations

Original Research

Published on 04 Feb 2022

Angiogenic Role of Mesothelium-Derived Chemokine CXCL1 During Unfavorable Peritoneal Tissue Remodeling in Patients Receiving Peritoneal Dialysis as Renal Replacement Therapy

in Alloimmunity and Transplantation

Rusan Ali Catar
Maria Bartosova
Edyta Kawka
Lei Chen
Iva Marinovic
Conghui Zhang
Hongfan Zhao
Dashan Wu
Daniel Zickler
Honorata Stadnik

Frontiers in Immunology

doi 10.3389/fimmu.2022.821681

6,067 views
17 citations

Original Research

Published on 23 Aug 2021

Blockade of Autophagy Prevents the Development and Progression of Peritoneal Fibrosis

in Experimental Pharmacology and Drug Discovery

Yingfeng Shi
Yan Hu
Yi Wang
Xiaoyan Ma
Lunxian Tang
Min Tao
Andong Qiu
Shougang Zhuang
Na Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2021.724141

6,483 views
26 citations

Original Research

Published on 23 Feb 2023

Histone deacetylase 8 inhibition prevents the progression of peritoneal fibrosis by counteracting the epithelial-mesenchymal transition and blockade of M2 macrophage polarization

in Inflammation

Xun Zhou
Hui Chen
Yingfeng Shi
Jinqing Li
Xiaoyan Ma
Lin Du
Yan Hu
Min Tao
Qin Zhong
Danying Yan

Frontiers in Immunology

doi 10.3389/fimmu.2023.1137332

9,920 views
26 citations

Articles

Requirement of Histone Deacetylase 6 for Interleukin-6 Induced Epithelial-Mesenchymal Transition, Proliferation, and Migration of Peritoneal Mesothelial Cells

Long-term peritoneal dialysate exposure modulates expression of membrane complement regulators in human peritoneal mesothelial cells

Thalidomide Suppresses Angiogenesis Through the Signal Transducer and Activator of Transcription 3/SP4 Signaling Pathway in the Peritoneal Membrane

Endoglin aggravates peritoneal fibrosis by regulating the activation of TGF-β/ALK/Smads signaling

Elabela Attenuates the TGF-β1-Induced Epithelial-Mesenchymal Transition of Peritoneal Mesothelial Cells in Patients Receiving Peritoneal Dialysis

LncRNA GAS5 Competitively Combined With miR-21 Regulates PTEN and Influences EMT of Peritoneal Mesothelial Cells via Wnt/β-Catenin Signaling Pathway

Angiogenic Role of Mesothelium-Derived Chemokine CXCL1 During Unfavorable Peritoneal Tissue Remodeling in Patients Receiving Peritoneal Dialysis as Renal Replacement Therapy

Blockade of Autophagy Prevents the Development and Progression of Peritoneal Fibrosis

Histone deacetylase 8 inhibition prevents the progression of peritoneal fibrosis by counteracting the epithelial-mesenchymal transition and blockade of M2 macrophage polarization